Biomarkers for Allogeneic HCT Outcomes

Biomarkers for Allogeneic HCT Outcomes

Allogeneic hematopoietic cell transplantation (HCT) remains the only curative therapy for many hematological malignant and non-malignant disorders. However, key obstacles to the success of HCT include graft-versus-host disease (GVHD) and disease relapse due to absence of graft-versus-tumor (GVT) eff...

Full description

Bibliographic Details
Main Authors:	Djamilatou Adom, Courtney Rowan, Titilayo Adeniyan, Jinfeng Yang, Sophie Paczesny
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-04-01
Series:	Frontiers in Immunology
Subjects:	biomarkers graft-versus-host disease graft-versus-tumor hematopoietic cell transplantation proteomics
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2020.00673/full

Similar Items

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
by: Hua Jiang, et al.
Published: (2021-10-01)

The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
by: Sophie Paczesny, et al.
Published: (2017-04-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants
by: Maria Iacobescu, et al.
Published: (2024-02-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE
by: Tariq Azam Khattak, et al.
Published: (2021-02-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation
by: Zhao Wang, et al.
Published: (2022-09-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
by: Jacob Rozmus, et al.
Published: (2022-03-01)

Acute Complications of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation and Their Effects on Survival: A Single-Center Experience in Korea
by: Kyoung Min Lee, et al.
Published: (2023-04-01)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
by: Dongsub Kim, et al.
Published: (2018-11-01)

Pericardial effusion and cardiac tamponade: clinical manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
by: David Cavalcanti Ferreira, et al.
Published: (2014-04-01)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
by: Raffaella Greco, et al.
Published: (2021-03-01)

Advances in graft-versus-host disease prevention strategies: latest updates from the 2022 ASH annual meeting
by: Yiyin Chen, et al.
Published: (2023-07-01)

Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study
by: Ayako Matsumura, et al.
Published: (2020-02-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells
by: Yu. R. Zalyalov, et al.
Published: (2022-11-01)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
by: Hannes Schmid, et al.
Published: (2018-08-01)

Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
by: Simonetta Saldi, et al.
Published: (2022-12-01)

Single-Nucleotide Polymorphisms in MICA and MICB Genes Could Play a Role in the Outcome in AML Patients after HSCT
by: Alena Machuldova, et al.
Published: (2021-10-01)

Lower expression of NOTCH components in peripheral blood mononuclear cells of allogeneic hematopoietic cell transplant patients
by: Marcos Paulo Colella, et al.
Published: (2023-07-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?
by: Xiao-Su Zhao, et al.
Published: (2019-08-01)

Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
by: Ashley N. Gray, et al.
Published: (2023-05-01)

Donor lymphocyte infusion in bone marrow transplantation therapy
by: Stephen Mackinnon, et al.
Published: (2002-04-01)

Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area
by: Hsin - Chen Lin, et al.
Published: (2017-05-01)

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation
by: Ying Yang, et al.
Published: (2022-09-01)

Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation
by: Eun Sil Kim, et al.
Published: (2023-08-01)

Immune Ablation and Stem Cell Rescue in Two Pediatric Patients with Progressive Severe Chronic Graft-Versus-Host Disease
by: Jaspar Kloehn, et al.
Published: (2022-12-01)

Extensive acute cutaneous graft versus host disease: A rare case report of survival
by: Prajwal Pudasaini, et al.
Published: (2023-06-01)

Anti-tumor necrosis factor-a for the treatment of steroid-refractory acute graft-versus-host disease
by: M.C. Nogueira, et al.
Published: (2007-12-01)

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
by: Andréa Z Pereira, et al.
Published: (2020-03-01)

Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft‐versus‐host disease by inhibiting T‐cell migration to the gastrointestinal tract
by: Yukie Tsubokura, et al.
Published: (2022-09-01)

Thoracic Air-Leakage Syndrome in Allogeneic Stem Cell Transplant Recipients as a Late Complication of Chronic Graft-versus-Host Disease: Case Reports
by: Jae Woo Park, et al.
Published: (2016-08-01)